ImpediMed Limited Price (IPD.AX)

Stock Price

Low: Year Low
High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Fetching Data...

Shares Outstanding

2,021,740,728

(12.2972)%

ImpediMed Performance History

Community Sentiment 0 votes
↑ 0% ↓ 0%

Description

ImpediMed Limited, a medical software technology company, develops, manufactures, and sells bioimpedance spectroscopy (BIS) devices and software services in Australia, North America, and internationally. The company offers SOZO, a noninvasive BIS device for the assessment of lymphedema and fluid status monitoring of heart failure patients; SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinar... Read More

Sector: Healthcare

  • Previous Close Fetching Data...
  • Range $0.0405-0.105
  • Market Cap 85.08M
  • Enterprise Value No Data
  • Avg Volume Fetching Data...
  • P/E Ratio Fetching Data...
  • Dividend Yield Fetching Data...

Industry: Medical - Devices

  • ceo: Dr. Parmjot Bains M.D.
  • IPO Date: October, 24, 2007
  • Country: AU
  • Currency: AUD
  • Headquaters: Pinkenba, QLD
  • Employees: 83

- Revenue from each product or segment:

Product or Segment Value: % - Total Last 3Y:
news-img

- Revenue by Region

Product or Segment Value: % - Total Last 3Y:
news-img
8 New Orders
close
Theme Customizer

Customize your theme

close

Theme variation